Radiotherapy enhances laser palliation of malignant dysphagia: a randomised study.

PubWeight™: 0.88‹?›

🔗 View Article (PMC 1027087)

Published in Gut on March 01, 1997

Authors

I R Sargeant1, J S Tobias, G Blackman, S Thorpe, J R Glover, S G Bown

Author Affiliations

1: National Medical Laser Centre, University College London NHS Trust.

Articles cited by this

A prospective comparison of laser therapy and intubation in endoscopic palliation for malignant dysphagia. Gastroenterology (1991) 2.18

Use of ethanol-induced tumor necrosis to palliate dysphagia in patients with esophagogastric cancer. Gastrointest Endosc (1990) 1.91

Comparison of low-power YAG laser and BICAP tumor probe for palliation of esophageal cancer strictures. Gastroenterology (1988) 1.25

Laser versus laser plus afterloading with iridium-192 in the palliative treatment of malignant stenosis of the esophagus: a prospective, randomized, and controlled study. Gastrointest Endosc (1991) 1.16

Palliative treatment of malignant stenoses of the upper gastrointestinal tract using a combination of laser and afterloading therapy. Endoscopy (1986) 1.15

Radiation enhancement of laser palliation for malignant dysphagia: a pilot study. Gut (1992) 1.09

The effect of radiotherapy on dysphagia and survival in patients with esophageal cancer. Radiother Oncol (1988) 0.97

101 oesophageal cancers: a surgeon uses radiotherapy. Ann R Coll Surg Engl (1990) 0.94

Combined endoscopic laser therapy and brachytherapy for palliation of oesophageal carcinoma: a pilot study. Gut (1992) 0.94

Palliation of malignant obstruction--use of lasers and radiotherapy in combination. Eur J Cancer (1991) 0.92

Endosonography in the clinical staging of esophagogastric carcinoma. Gastrointest Endosc (1990) 0.91

Non-optic endosonography in advanced carcinoma of the esophagus. Gastrointest Endosc (1994) 0.81

Articles by these authors

Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer. Lancet (2005) 11.05

Support for the prion hypothesis for inheritance of a phenotypic trait in yeast. Science (1996) 7.24

Variations in breast cancer management between a teaching and a non-teaching district. Eur J Cancer (1992) 5.54

Informed consent in medical research. BMJ (1998) 4.57

HSP100/Clp proteins: a common mechanism explains diverse functions. Trends Biochem Sci (1996) 4.27

Variations in behavior and condition of a Southern Ocean top predator in relation to in situ oceanographic conditions. Proc Natl Acad Sci U S A (2007) 3.04

Prognostic significance of laboratory parameters measured at diagnosis in small cell carcinoma of the lung. Cancer Res (1985) 2.62

Back pain: a randomized clinical trial of rotational manipulation of the trunk. Br J Ind Med (1974) 2.47

Financial ties as part of informed consent to postmarketing research. Attitudes of American doctors and patients. BMJ (1995) 2.36

Controlled trial of argon laser photocoagulation in bleeding peptic ulcers. Lancet (1981) 2.36

The cyclotron saga continues. BMJ (1989) 2.34

Interstitial laser hyperthermia: a new approach to local destruction of tumours. BMJ (1989) 2.28

Endoscopic prediction of recurrent bleeding in peptic ulcers. N Engl J Med (1981) 2.19

Radiotherapy in small cell cancer of the lung treated with combination chemotherapy: a controlled trial. Br Med J (Clin Res Ed) (1984) 2.19

A prospective comparison of laser therapy and intubation in endoscopic palliation for malignant dysphagia. Gastroenterology (1991) 2.18

Effects of exposure to slate dust in North Wales. Br J Ind Med (1980) 2.09

Diagnosis of breast cancer using elastic-scattering spectroscopy: preliminary clinical results. J Biomed Opt (2000) 2.09

Hepatic metastases: interstitial laser photocoagulation with real-time US monitoring and dynamic CT evaluation of treatment. Radiology (1993) 2.03

Fluorescence distribution and photodynamic effect of ALA-induced PP IX in the DMH rat colonic tumour model. Br J Cancer (1992) 2.00

Photosensitisation and photodynamic therapy of oesophageal, duodenal, and colorectal tumours using 5 aminolaevulinic acid induced protoporphyrin IX--a pilot study. Gut (1995) 1.89

Duration of chemotherapy in small cell lung cancer: a Cancer Research Campaign trial. Br J Cancer (1989) 1.81

Who should treat cancer? Lancet (1981) 1.81

Elastic scattering spectroscopy accurately detects high grade dysplasia and cancer in Barrett's oesophagus. Gut (2006) 1.78

Op-Site skin closure: a comparison with subcuticular and interrupted sutures. Ann R Coll Surg Engl (1983) 1.76

Emotional support for cancer patients: what do patients really want? Br J Cancer (1996) 1.72

A limit to the speed of processing in ultra-rapid visual categorization of novel natural scenes. J Cogn Neurosci (2001) 1.70

Interstitial laser photocoagulation for the treatment of osteoid osteoma. J Bone Joint Surg Br (2000) 1.68

Oral versus intravenous administration of 5-aminolaevulinic acid for photodynamic therapy. Br J Cancer (1993) 1.62

Controlled trial of Nd-YAG laser photocoagulation in bleeding peptic ulcers. Lancet (1986) 1.62

Synchronous chemoradiation for squamous carcinomas. BMJ (2001) 1.61

The contrasting mechanisms of colonic collagen damage between photodynamic therapy and thermal injury. Photochem Photobiol (1987) 1.61

A cellular analogue of visual cortical plasticity. Nature (1988) 1.59

Photodynamic therapy with porphyrin and phthalocyanine sensitisation: quantitative studies in normal rat liver. Br J Cancer (1986) 1.58

Argon laser photocoagulation in the dog stomach. Gut (1979) 1.56

Phototherapy in tumors. World J Surg (1983) 1.55

Photodynamic therapy of oral cancer: photosensitisation with systemic aminolaevulinic acid. Lancet (1993) 1.54

Biological effects of intrahepatic neodymium:yttrium-aluminum-garnet laser photocoagulation in rats. Gastroenterology (1987) 1.54

Aluminum sulfonated phthalocyanine distribution in rodent tumors of the colon, brain and pancreas. Photochem Photobiol (1987) 1.53

Nature of the bleeding vessel in recurrently bleeding gastric ulcers. Gastroenterology (1986) 1.50

Interstitial laser photocoagulation as a treatment for breast cancer. Br J Surg (1994) 1.48

Management of ovarian carcinoma. Current concepts and future prospects (first of two parts). N Engl J Med (1976) 1.43

Endogenous porphyrin distribution induced by 5-aminolaevulinic acid in the tissue layers of the gastrointestinal tract. J Photochem Photobiol B (1993) 1.42

Targeted intra-operative radiotherapy (Targit): an innovative method of treatment for early breast cancer. Ann Oncol (2001) 1.39

An open randomised trial of second-line endocrine therapy in advanced breast cancer: comparison of the Aromatase inhibitors letrozole and anastrozole. Eur J Cancer (2004) 1.39

Rapid diagnosis of testicular tumour. Br J Hosp Med (1992) 1.39

Photodynamic therapy in the normal rat colon with phthalocyanine sensitisation. Br J Cancer (1987) 1.38

Quality of life during chemotherapy for small cell lung cancer: assessment and use of a daily diary card in a randomized trial. Eur J Cancer (1990) 1.37

Photodynamic therapy using 5-aminolevulinic acid for premalignant and malignant lesions of the oral cavity. Cancer (1996) 1.37

Interstitial and transurethral photodynamic therapy of the canine prostate using meso-tetra-(m-hydroxyphenyl) chlorin. Int J Cancer (1996) 1.36

Patients at risk of chemotherapy-associated toxicity in small cell lung cancer. Br J Cancer (1989) 1.32

Interstitial photodynamic therapy in the canine prostate with disulfonated aluminum phthalocyanine and 5-aminolevulinic acid-induced protoporphyrin IX. Prostate (1997) 1.29

Photodynamic therapy: an effective, but non-selective treatment for superficial cancers of the oral cavity. Int J Cancer (1997) 1.22

Selective necrosis in dimethylhydrazine-induced rat colon tumors using phthalocyanine photodynamic therapy. Gastroenterology (1990) 1.21

Dynamics of orientation coding in area V1 of the awake primate. Vis Neurosci (1993) 1.20

Photodynamic therapy using meso tetra hydroxy phenyl chlorin (mTHPC) in early prostate cancer. Lasers Surg Med (2006) 1.20

Spinal cord compression in small cell lung cancer: a retrospective study of 610 patients. Br J Cancer (1989) 1.20

Mouse skin photosensitivity with dihaematoporphyrin ether (DHE) and aluminium sulphonated phthalocyanine (AlSPc): a comparative study. Photochem Photobiol (1989) 1.19

A randomised trial of planned versus as required chemotherapy in small cell lung cancer: a Cancer Research Campaign trial. Br J Cancer (1991) 1.19

Interstitial photodynamic therapy as salvage treatment for recurrent head and neck cancer. Br J Cancer (2004) 1.19

Comparison of distribution and photodynamic effects of di- and tetra-sulphonated aluminium phthalocyanines in normal rat colon. Photochem Photobiol (1991) 1.16

Combined amphotericin B-flucytosine therapy in Aspergillus pneumonia. JAMA (1979) 1.15

The morphological and functional changes in rat bladder following photodynamic therapy with phthalocyanine photosensitization. J Urol (1991) 1.14

Photodynamic therapy of the normal rat stomach: a comparative study between di-sulphonated aluminium phthalocyanine and 5-aminolaevulinic acid. Br J Cancer (1992) 1.14

Endoscopic treatment of inoperable colorectal cancers with the Nd YAG laser. Br J Surg (1986) 1.12

Experimental studies to assess the potential of photodynamic therapy for the treatment of bronchial carcinomas. Thorax (1993) 1.11

NdYAG laser photocoagulation in the dog stomach. Gut (1980) 1.11

PAY4, a gene required for peroxisome assembly in the yeast Yarrowia lipolytica, encodes a novel member of a family of putative ATPases. J Biol Chem (1994) 1.11

Photodynamic therapy for colorectal cancer: a quantitative pilot study. Br J Surg (1990) 1.11

Clinical staging in multiple myeloma. Br J Haematol (1979) 1.11

Laser ablation of upper gastrointestinal vascular ectasias: long term results. Gut (1993) 1.09

Radiation enhancement of laser palliation for malignant dysphagia: a pilot study. Gut (1992) 1.09

Rate coding versus temporal order coding: a theoretical approach. Biosystems (1999) 1.08

What went wrong at Exeter? BMJ (1988) 1.08

Photodynamic therapy using 5-aminolaevulinic acid for experimental pancreatic cancer--prolonged animal survival. Br J Cancer (1994) 1.07

Social consequences of brain or liver relapse in small cell carcinoma of the bronchus. Radiother Oncol (1985) 1.06

Purification and Characterization of Methionine:Glyoxylate Aminotransferase from Brassica carinata and Brassica napus. Plant Physiol (1990) 1.05

Endoscopic laser treatment of vascular anomalies of the upper gastrointestinal tract. Gut (1985) 1.05

Combination antifungal therapy for cryptococcal meningitis. Postgrad Med J (1976) 1.04

Enhancement of photodynamic therapy with 5-aminolaevulinic acid-induced porphyrin photosensitisation in normal rat colon by threshold and light fractionation studies. Br J Cancer (1995) 1.03

Local eradication of rat colon cancer with photodynamic therapy: correlation of distribution of photosensitiser with biological effects in normal and tumour tissue. Gut (1991) 1.03

The killing of Helicobacter pylori by low-power laser light in the presence of a photosensitiser. J Med Microbiol (1996) 1.03

Photodynamic therapy using mTHPC for malignant disease in the oral cavity. Int J Cancer (1997) 1.02

Histological changes following Nd YAG laser photocoagulation of canine gastric mucosa. Gut (1983) 1.02

Selective necrosis in hamster pancreatic tumours using photodynamic therapy with phthalocyanine photosensitization. Br J Surg (1992) 1.01

Ex-vivo treatment of gastric Helicobacter infection by photodynamic therapy. J Photochem Photobiol B (1996) 1.00

Photodynamic therapy for polyps in familial adenomatous polyposis--a pilot study. Eur J Cancer (1995) 1.00

Distribution and photodynamic effect of disulphonated aluminium phthalocyanine in the pancreas and adjacent tissues in the Syrian golden hamster. Br J Cancer (1991) 1.00

Combination chemotherapy with adriamycin-cyclophosphamide for advanced ovarian carcinoma. Cancer (1980) 1.00

Photodynamic therapy with phthalocyanine sensitisation: quantitative studies in a transplantable rat fibrosarcoma. Br J Cancer (1987) 1.00

Increasing the effect of photodynamic therapy on the RIF-1 murine sarcoma, using the bioreductive drugs RSU1069 and RB6145. Br J Cancer (1992) 1.00

Peroxisome biogenesis in yeast. Mol Microbiol (1992) 1.00

Doing the best for the cancer patient. Lancet (1985) 0.99

Chemoradiotherapy with or without induction chemotherapy for locally advanced pancreatic cancer: a UK multi-institutional experience. Clin Oncol (R Coll Radiol) (2010) 0.98

The detection of phthalocyanine fluorescence in normal rat bladder wall using sensitive digital imaging microscopy. Br J Cancer (1991) 0.98

Photodynamic therapy of malignant and premalignant lesions in patients with 'field cancerization' of the oral cavity. J Laryngol Otol (1993) 0.97

Randomized comparison of Nd YAG laser, heater probe, and no endoscopic therapy for bleeding peptic ulcers. Gastroenterology (1990) 0.97

Face processing using one spike per neurone. Biosystems (1999) 0.96